People who had a heart attack and started taking a cholesterol drug called ezetimibe early had fewer heart problems over the next year compared to those who started later or didn’t take it at all.

Out of nearly 36,000 people hospitalized for heart attacks, most didn't get a cholesterol drug called ezetimibe—even though almost all were already on strong statins. Only about 1 in 6 got it early, and a similar number got it later.

If you've had a heart attack, starting a cholesterol drug called ezetimibe within 3 months might lower your chance of dying from heart problems over the next 3 years, compared to waiting or not taking it at all.

If someone has a heart attack and starts taking a cholesterol drug called ezetimibe within 3 months, they’re less likely to have another heart problem in the next 3 years compared to those who wait longer or never start it.

For people who've had a recent heart problem, taking ezetimibe with their cholesterol medicine (a statin) helps prevent heart attacks and strokes over 7 years — and doesn't seem to cause extra cancer or liver issues.

If someone has a heart attack and hasn’t taken cholesterol drugs before, waiting more than 12 weeks to start a drug called ezetimibe might increase their risk of future heart problems — though the data isn’t strong enough to be sure.